ADCT
NYSE · Biotechnology
Adc Therapeutics Sa
$3.94
-0.11 (-2.72%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+396.7% upside
Low Target
$11.03
Average Target
$19.57
High Target
$23.80
Current Price
$3.94
Current
$3.94
$3.94
Target
$19.57
$19.57
$11.03
$19.57 avg
$23.80
Scenario Analysis
Bear Case
$11.03
179.9%
Low target
Base Case
$19.57
+396.7%
Avg target
Bull Case
$23.80
+504.1%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$4.80
-17.9% from high
52-Week Low
$1.05
+275.2% from low
Target vs 52W High
$19.57
+307.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |